Corganics® Clinical CBD Joins MedResults Network's Offering
Corganics, healthcare professionals’ most trusted and recommended clinical cannabinoid (CBD) company, has announced their new partnership with MedResults Network (MRN), a purchasing group that provides products and services to over 3,400 aesthetic medical practices and med spas.
Co-Founders, Chad Collins and Reggie Gatewood both shared that, “We are excited to announce this partnership with MedResults Network. They have a strong, clinical outlook on how Corganics Clinical CBD can support their patients’ health journey on multiple levels. MedResults Network trusts Corganics to provide the highest quality, safest, and most transparent product offering when it comes to cannabinoid therapy, and we are honored to have been selected as a partner for MedResults Network.”
MRN selects partners that are the best in their field to ensure a high-value collaboration for the aesthetic medical practices in their Network. This strategic partnership with MedResults Network is the next step on Corganics’ mission of bridging the gap between healthcare professionals and their patients when it comes to understanding and treating the endocannabinoid system.
MedResults Network CEO, Jeff Routledge, said about this most recent venture, “We’re thrilled to partner with Corganics Clincal CBD to offer scientifically formulated and physician advised, broad-spectrum CBD products to our member practices and med spas. With the Corganics Clinical CBD products, our 1,400 med spa members can now offer something to patients that addresses pain relief. Additionally, our 800+ surgery practices now have a reliable and proven alternative to prescribing Schedule II pain medications.”
Available exclusively through healthcare professionals, Corganics utilize the latest, science-backed methods to create broad spectrum, THC-free CBD formulations that are vigorously tested. Routledge commented further, stating, “MedResults Network is committed to delivering cutting-edge medical products and services, and Corganics felt like a natural fit as they are committed to providing top-tier CBD product solutions that are developed with the patient in mind. We’re excited to offer this multimodal option to our members, a clinical option that addresses patient pain and inflammation without the evident risks associated with traditional medications.”
Corganics is a Dallas-based life sciences company that provides scientifically formulated and physician advised products including clinical cannabinoid therapies and other natural products with the highest quality and manufacturing standards. Corganics’ clinical cannabinoid therapy portfolio is available exclusively through healthcare professionals. Corganics operates a Clinical Division as well as a Consumer Health Division with distribution across the continental U.S. and other regional countries.
About MedResults Network
Established in 2008, MedResults Network is the largest aesthetic buying group in the USA with 3,400 member practices and med spas in all 50 states. Members have access to deep discounts and rebates on thousands of products and services including injectables, devices, and med/surg supplies. MedResults Network’s membership is free to practices and med spas.